«No-reflow» phenomenon: clinical aspects of reperfusion failure
- Authors: Iskhakov MM1, Tagirova DR1, Gazizov NV1, Nugaybekova LA2, Sayfutdinov RG1,2
-
Affiliations:
- Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia
- Kazan State Medical Academy, Kazan, Russia
- Issue: Vol 96, No 3 (2015)
- Pages: 391-396
- Section: Reviews
- URL: https://journals.rcsi.science/kazanmedj/article/view/1672
- DOI: https://doi.org/10.17750/KMJ2015-391
- ID: 1672
Cite item
Full Text
Abstract
About the authors
M M Iskhakov
Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia
Author for correspondence.
Email: laynug@gmail.com
D R Tagirova
Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia
Email: laynug@gmail.com
N V Gazizov
Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia
Email: laynug@gmail.com
L A Nugaybekova
Kazan State Medical Academy, Kazan, Russia
Email: laynug@gmail.com
R G Sayfutdinov
Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia; Kazan State Medical Academy, Kazan, Russia
Email: laynug@gmail.com
References
- Голощапов-Аксёнов Р.С., Терновых М.В., Лебедев А.В. и др. Применение фильтра-проводника для профилактики феномена «no-reflow» при эндоваскулярной реваскуляризации коронарных артерий у больного острым инфарктом миокарда // Диагност. и интервенц. радиол. - 2012. - Т. 6, №3-1. - С. 73-80.
- Коваль М. Феномен «no-reflow» - ложка дёгтя в бочке меда реваскуляризации // Med. Review. - 2008. - №5 (05). - С. 32-36.
- Крыжановская С.А., Матюшин Г.В., Протопопов А.В. Феномен «no-reflow»: факторы, определяющие риск развития и особенности ЭКГ-изменений // Функционал. диагн. - 2011. - №3. - С. 82.
- Пархоменко А.Н. Феномен невосстановленного кровотока у больных с острым коронарным синдромом и возможные пути улучшения тканевой перфузии // Украин. кардиол. ж. - 2007. - №5. - С. 17-25.
- Певзнер Д.В., Староверов И.И., Самко А.Н., Мазуров А.В. и др. Применение антагониста гликопротеинов IIb-IIIа монафрама при первичной ангиопластике у больных с острым коронарным синдромом без подьёма сегмента ST // Кардиология. - 2010. - Т. 50, №6. - С. 22-26.
- Сидоренко Г.И., Островский Ю.П. Феномен «невозобновления кровотока» (no-reflow) и его клиническое значение // Кардиология. - 2002. - Т. 42, №5. - С. 74-80.
- Anderson J.L., Adams C.D., Antman E.M. et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non_ST_elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) // J. Am. Coll. Cardiol. - 2007. - Vol. 50. - P. 652-726. http://dx.doi.org/10.1016/j.jacc.2007.02.028
- De Lemos J.A., Antman E.M., Giugliano R.P. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy: Thrombolysis in Myocardial Infarction (TIMI) 14 investigators // Am. J. Cardiol. - 2000. - Vol. 85. - P. 299-304. http://dx.doi.org/10.1016/S0002-9149(99)00736-5
- Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies // Eur. Heart J. - 2001. - Vol. 22. - P. 729-739. http://dx.doi.org/10.1053/euhj.2000.2172
- Elbarouni B., Goodman S.G., Yan R.T. et al. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada // Am. Heart. J. - 2009. - Vol. 158. - P. 392-399. http://dx.doi.org/10.1016/j.ahj.2009.06.010
- Fischell T.A. Pharmaceutical interventions for the management of no-reflow // J. Invasive Cardiol. - 2008. - Vol. 20, N 7. - Р. 374-379.
- Giampaolo N., Buzzotta F., Gialuto L., Crea F. Myocardial no-reflow in humans // JACC. - 2009. - Vol. 54, N 4. - P. 281-292. http://dx.doi.org/10.1016/j.jacc.2009.03.054
- Henriques J., Zijlstra F., Ottervanger J. et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction // Eur. Heart J. - 2002. - Vol. 23. - P. 1112-1117. http://dx.doi.org/10.1053/euhj.2001.3035
- Herrmann J., Lerman A., Baumgart D. et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction // Circulation. - 2002. - Vol. 106. - P. 2180-2183. http://dx.doi.org/10.1161/01.CIR.0000037520.89770.5E
- Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction // Nat. Clin. Pract. Cardiovasc. Med. - 2006. - Vol. 3. - P. 499-506. http://dx.doi.org/10.1038/ncpcardio0632
- Kaul S., Ito H. Microvasculature in acute myocardial ischemia // Circulation. - 2004. - Vol. 109. - P. 146-149. http://dx.doi.org/10.1161/01.CIR.0000111582.02736.CD
- Lee K.W., Norell M.S. Management of «no-reflow» complicating reperfusion therapy // Acute Card. Care. - 2008. - Vol. 10, N 1. - Р. 5-14.
- Ndrepepa G., Tiroch K., Fusaro M. et al. Five-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction // J. Am. Coll. Cardiol. - 2010. - Vol. 55. - P. 2383-2389. http://dx.doi.org/10.1016/j.jacc.2009.12.054
- Paul A. Grabern, Choi J.W. Advances in the assessment of no-reflow after successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction // JACC. - 2008. - Vol. 51, N 5. - P. 566-568. http://dx.doi.org/10.1016/j.jacc.2007.10.024
- Porto I., Ashar V., Mitchell A.R. Pharmacological management of no reflow during percutaneous coronary intervention // Curr. Vasc. Pharmacol. - 2006. - Vol. 4, N 2. - P. 95-100. http://dx.doi.org/10.2174/157016106776359835
- Rezkalla S.H., Kloner R.A. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory // Catheter Cardiovasc. Interv. - 2008. - Vol. 72, N 7. - P. 950-957. http://dx.doi.org/10.1002/ccd.21715
- Theilmeier G., Verhamme P., Dymarkowski M. et al. Hypercholesterolemia in minipigs impairs left ventricular response to stress: association with decreased coronary flow reserve and reduced capillary density // Circulation. - 2002. - Vol. 106. - P. 1140-1146. http://dx.doi.org/10.1161/01.CIR.0000026805.41747.54
- Valero S.J., Moreno R., Reyes R.M. et al. Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions // Cardiovasc. Hematol. Agents Med. Chem. - 2008. - Vol. 6, N 2. - Р. 125-129.
- Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology // Eur. Heart J. - 2008. - Vol. 29. - Р. 2909-2945.
- Van Gaal W.J., Banning A.P. Percutaneous coronary intervention and the no-reflow phenomenon // Expert Rev. Cardiovasc. Ther. - 2007. - Vol. 5, N 4. - P. 715-731. http://dx.doi.org/10.1586/14779072.5.4.715